Supplemental material
Emerging Microbes & Infections
Volume 7, 2018 - Issue 1
Original Articles
N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro
, , , , , , , , , , , , , , , , 
& show all
Shaowei LiState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life SciencesXiamen University361102XiamenChina;National Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Public HealthXiamen University361102XiamenChinaCorrespondence[email protected]
http://orcid.org/0000-0002-3374-1038
http://orcid.org/0000-0002-3374-1038 & show allRelated Research Data
Diseases associated with human papillomavirus infection.
Source:
Elsevier BV
Subunit interactions in bovine papillomavirus
Source:
Proceedings of the National Academy of Sciences
A deletion and point mutation study of the human papillomavirus type 16 major capsid gene.
Source:
Elsevier BV
Analysis of Modified Human Papillomavirus Type 16 L1 Capsomeres: the Ability To Assemble into Larger Particles Correlates with Higher Immunogenicity
Source:
American Society for Microbiology
A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates.
Source:
Elsevier BV
Expression of the major capsid protein of human papillomavirus type 16 in Escherichia coli
Source:
Elsevier BV
Cross-roads in the classification of papillomaviruses
Source:
Elsevier BV
RELION: implementation of a Bayesian approach to cryo-EM structure determination.
Source:
Elsevier BV
Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1.
Source:
Elsevier BV
Papillomavirus-like particles and HPV vaccine development.
Source:
Elsevier BV
Characterization of an Escherichia coli-derived human papillomavirus type 16 and 18 bivalent vaccine.
Source:
Elsevier BV
Cryoelectron Microscopy Maps of Human Papillomavirus 16 Reveal L2 Densities and Heparin Binding Site
Source:
Elsevier BV
Production of hybridomas secreting antibodies to the cornea.
Source:
Informa UK Limited
Expression of Human Papillomavirus Type 16 L1 Protein in Escherichia coli: Denaturation, Renaturation, and Self-Assembly of Virus-like Particles in Vitro
Source:
Elsevier BV
A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
Source:
Massachusetts Medical Society
Enhanced papillomavirus-like particle production in insect cells.
Source:
Elsevier BV
Arrangement of L2 within the Papillomavirus Capsid
Source:
American Society for Microbiology
Purification and immunogenicity study of human papillomavirus type 16 L1 protein in Saccharomyces cerevisiae.
Source:
Elsevier BV
Increasing the expression levels of papillomavirus major capsid protein in Escherichia coli by N-terminal deletion.
Source:
Elsevier BV
Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18
Source:
Elsevier BV
Packaging of a Polymer by a Viral Capsid: The Interplay between Polymer Length and Capsid Size
Source:
The Biophysical Society. Published by Elsevier Inc.
Structural basis for the neutralization of hepatitis E virus by a cross-genotype antibody.
Source:
Springer Science and Business Media LLC
Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
Source:
BioMed Central
Expression of human papillomavirus type 6 and type 16 capsid proteins in bacteria and their antigenic characterization.
Source:
Microbiology Society
The C-Terminal Arm of the Human Papillomavirus Major Capsid Protein Is Immunogenic and Involved in Virus-Host Interaction.
Source:
eScholarship, University of California
N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro
Source:
Taylor & Francis
Linking provided by
